Literature DB >> 28034913

IL-10 distinguishes a unique population of activated, effector-like CD8+ T cells in murine acute liver inflammation.

Julia E Rood1,2, Scott W Canna3, Lehn K Weaver1, John W Tobias4, Edward M Behrens5,2.   

Abstract

Immune-mediated liver injury is a central feature of hyperinflammatory diseases, such as hemophagocytic syndromes, yet the immunologic mechanisms underlying those processes are incompletely understood. In this study, we used the toll-like receptor 9 (TLR9)-mediated model of a hemophagocytic syndrome known as macrophage activation syndrome (MAS) to dissect the predominant immune cell populations infiltrating the liver during inflammation. We identified CD8+ T cells that unexpectedly produce interleukin-10 (IL-10) in addition to interferon-γ (IFN-γ) as a major hepatic population induced by TLR9 stimulation. Despite their ability to produce this anti-inflammatory cytokine, IL-10+ hepatic CD8+ T cells in TLR9-MAS mice did not resemble CD8+ T suppressor cells. Instead, the induction of these cells occurred independently of antigen stimulation and was partially dependent on IFN-γ. IL-10+ hepatic CD8+ T cells demonstrated an activated phenotype and high turnover rate, consistent with an effector-like identity. Transcriptional analysis of this population confirmed a gene signature of effector CD8+ T cells yet suggested responsiveness to liver injury-associated growth factors. Together, these findings suggest that IL-10+ CD8+ T cells induced by systemic inflammation to infiltrate the liver have initiated an inflammatory, rather than regulatory, program and may thus have a pathogenic role in severe, acute hepatitis. © Society for Leukocyte Biology.

Entities:  

Keywords:  cytokine; hemophagocytic syndrome; hepatitis

Mesh:

Substances:

Year:  2016        PMID: 28034913      PMCID: PMC5346180          DOI: 10.1189/jlb.3A0916-221RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  40 in total

1.  Selective retention of activated CD8+ T cells by the normal liver.

Authors:  W Z Mehal; A E Juedes; I N Crispe
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

Review 2.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

3.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

Review 4.  Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokine-driven immune disorders.

Authors:  Ellen Brisse; Carine H Wouters; Patrick Matthys
Journal:  Cytokine Growth Factor Rev       Date:  2014-10-28       Impact factor: 7.638

5.  Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

Authors:  Edward M Behrens; Scott W Canna; Katharine Slade; Sheila Rao; Portia A Kreiger; Michele Paessler; Taku Kambayashi; Gary A Koretzky
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

6.  CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL.

Authors:  Doreen E Wesche-Soldato; Chun-Shiang Chung; Stephen H Gregory; Thais P Salazar-Mather; Carol A Ayala; Alfred Ayala
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

7.  Control of effector CD8+ T cell function by the transcription factor Eomesodermin.

Authors:  Erika L Pearce; Alan C Mullen; Gislâine A Martins; Connie M Krawczyk; Anne S Hutchins; Valerie P Zediak; Monica Banica; Catherine B DiCioccio; Darrick A Gross; Chai-An Mao; Hao Shen; Nezih Cereb; Soo Y Yang; Tullia Lindsten; Janet Rossant; Christopher A Hunter; Steven L Reiner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728

8.  Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.

Authors:  Scott W Canna; Julia Wrobel; Niansheng Chu; Portia A Kreiger; Michele Paessler; Edward M Behrens
Journal:  Arthritis Rheum       Date:  2013-07

9.  Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.

Authors:  Catherine E Terrell; Michael B Jordan
Journal:  Blood       Date:  2013-05-09       Impact factor: 22.113

10.  Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis.

Authors:  Muhaimin Rifa'i; Yoshiyuki Kawamoto; Izumi Nakashima; Haruhiko Suzuki
Journal:  J Exp Med       Date:  2004-11-01       Impact factor: 14.307

View more
  4 in total

1.  Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis.

Authors:  E Brisse; M Imbrechts; T Mitera; J Vandenhaute; N Berghmans; L Boon; C Wouters; R Snoeck; G Andrei; P Matthys
Journal:  Clin Exp Immunol       Date:  2018-01-18       Impact factor: 4.330

2.  Methane alleviates carbon tetrachloride induced liver injury in mice: anti-inflammatory action demonstrated by increased PI3K/Akt/GSK-3β-mediated IL-10 expression.

Authors:  Ying Yao; Liping Wang; Peipei Jin; Na Li; Yan Meng; Changli Wang; Mengda Xu; Yan Zhang; Jinjun Bian; Xiaoming Deng
Journal:  J Mol Histol       Date:  2017-06-09       Impact factor: 2.611

Review 3.  Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experience.

Authors:  Martin Oft
Journal:  Semin Immunol       Date:  2019-11-06       Impact factor: 11.130

4.  Eosinophils Control Liver Damage by Modulating Immune Responses Against Fasciola hepatica.

Authors:  Sofía Frigerio; Valeria da Costa; Monique Costa; María Florencia Festari; Mercedes Landeira; Santiago A Rodríguez-Zraquia; Steffen Härtel; Jorge Toledo; Teresa Freire
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.